ARCHIVES

Group Chairmen Accept Most Changes In Terms Of Award, Object To CTEP Adjustments

This article is from The Cancer Letter archive.

Vol. 14 No. 47 | December 2, 1988

Download PDF Visit The Full Archive

Related Articles

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

April 30, 2010

Annual Report Finds Decreases In Overall Cancer Rates

December 11, 2009

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

January 27, 2012

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

March 7, 2008

“Dog And Pony Show” At FCRF For NCAB OFF

April 25, 1980

FTE Shortage Hurting Cancer and AIDS Research, Advisors Told; NCI Seeks Major Share Of New Slots

October 14, 1988